H Sinzinger
Impact in
- Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology
- Antioxidant Activity and Oxidative Stress
- Hematology top 10%
- Platelet Disorders and Treatments
Papers in
- Hematology 42
- Platelet Disorders and Treatments 35
- Blood Coagulation and Thrombosis Mechanisms 10
- Biochemistry 26
- Eicosanoids and Hypertension Pharmacology 26
- Co-authors
- Karl Silberbauer (18 shared papers)Peter Fitscha (24 shared papers)J Kaliman (21 shared papers)Anthony Oguogho (5 shared papers)H Kritz (9 shared papers)Peter Angelberger (5 shared papers)C Leithner (10 shared papers)W Feigl (5 shared papers)
In The Last Decade
H Sinzinger
118 papers receiving 650 citations
Peers
Comparison fields: 5 of 75
- Biochemistry 105
- Hematology 127
- Pharmacology 102
- Biochemistry 45
- Genetics 33
Countries citing papers authored by H Sinzinger
This map shows the geographic impact of H Sinzinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Sinzinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Sinzinger more than expected).
Fields of papers citing papers by H Sinzinger
This network shows the impact of papers produced by H Sinzinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Sinzinger. The network helps show where H Sinzinger may publish in the future.
Co-authors
The 25 scholars most cited alongside H Sinzinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 123 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1979 | 38 | |
| 2 | Effect of experimentally induced diabetes on swine vascular prostacyclin (PGI2) synthesis. | 1980 | 32 |
| 3 | Increased plasma, serum and urinary 8-epi-prostaglandin F2 alpha in heterozygous hypercholesterolemia. | 1999 | 22 |
| 4 | Enhanced prostacyclin availability of blood vessels in uraemic humans and rats. | 1978 | 21 |
| 5 | [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]. | 1985 | 20 |
| 6 | Endothelial dysfunction, atherosclerosis and diabetes. | 1999 | 20 |
| 7 | Regulation of human lymph contractility by prostaglandins and thromboxane. | 1984 | 18 |
| 8 | 1991 | 17 | |
| 9 | 1996 | 17 | |
| 10 | Effect of iloprost on in vivo and in vitro platelet function in patients with peripheral vascular disease (PVD). | 1987 | 16 |
| 11 | 2008 | 16 | |
| 12 | 1989 | 15 | |
| 13 | Isoprostanes in atherosclerosis. | 2000 | 14 |
| 14 | 1988 | 13 | |
| 15 | 1988 | 12 | |
| 16 | Influence of calcium antagonists on platelet function and vascular prostacyclin production. | 1994 | 12 |
| 17 | 1997 | 12 | |
| 18 | 2001 | 12 | |
| 19 | 1975 | 11 | |
| 20 | 1981 | 11 |
About H Sinzinger
H Sinzinger is a scholar working on Hematology, Biochemistry, Pharmacology, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging, having authored 123 papers that have together received 746 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (35 papers), Inflammatory mediators and NSAID effects (27 papers), Eicosanoids and Hypertension Pharmacology (26 papers), Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Blood Coagulation and Thrombosis Mechanisms (10 papers), Atherosclerosis and Cardiovascular Diseases (10 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Lipoproteins and Cardiovascular Health (8 papers). The work is most often cited by research in Biochemistry (105 citations), Hematology (127 citations), Pharmacology (102 citations), Biochemistry (45 citations) and Genetics (33 citations). H Sinzinger has collaborated with scholars based in Austria, Italy and Germany. Frequent co-authors include Karl Silberbauer, Peter Fitscha, J Kaliman, Anthony Oguogho, H Kritz, Peter Angelberger, C Leithner, W Feigl, Gerit-Holger Schernthaner and M. Winter. Their work appears in journals such as Nuclear Medicine Communications, Thrombosis and Haemostasis, Cells Tissues Organs, The Lancet and Prostaglandins Leukotrienes and Essential Fatty Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.